SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Regenthal, R
Right arrow Articles by Preiss, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Regenthal, R
Right arrow Articles by Preiss, R
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Poisoning with tilidine and naloxone: toxicokinetic and clinical observations

R Regenthal

Institute of Clinical Pharmacology, University of Leipzig, Härtelstrasse 16-18, 04107 Leipzig

M Krüger

Institute of Clinical Pharmacology, University of Leipzig, Härtelstrasse 16-18, 04107 Leipzig

M Richter

South East District Hospital of Leipzig, Department of Intensive Care, Chemnitzer Strasse 50, 04289 Leipzig, Germany

R Preiss

Institute of Clinical Pharmacology, University of Leipzig, Härtelstrasse 16-18, 04107 Leipzig

The opioid analgesic tilidine and its metabolites were detected by high performance liquid chromatography (HPLC) with UV-detection in serum from a 28 year-old woman who ingested 100 ml Valoron8N containing 6.94 g of tilidine and about 0.56 g of naloxone with suicidal intention.

Data on the toxicokinetics of tilidine in severe poisonings are missing. Therefore we followed serum concentrations of tilidine and metabolites for 48 or 96 h and for the first time calculated basic kinetic parameters in a massive life threatening poisoning.

Serum concentration of tilidine 3 h after ingestion was 38.1 mg/l which is about 70 times of the upper therapeutic level in man and about ninefold above toxic concentrations known so far. The concentration of nortilidine, the primary active metabolite at this time was 18.8 mg/l. The terminal elimination half life's of tilidine and nortilidine were explicit, prolonged with 23.9 and 13.9 h respectively.

The competitive opiate antagonist naloxone, which is added as a part of the industrially produced preparation Valoron8N solution to minimise oral abuse is not able to prevent ventilatory depression in massive overdoses.

Key Words: tilidine • naloxone • Valoron8N • toxicokinetics • poisoning

Human & Experimental Toxicology, Vol. 17, No. 11, 593-597 (1998)
DOI: 10.1177/096032719801701101


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement